Literature DB >> 22466758

Overexpression of ZEB1 associated with metastasis and invasion in patients with gastric carcinoma.

Baoqing Jia1, Hongyi Liu, Qinglong Kong, Bing Li.   

Abstract

The aim of this study was to investigate the expression of ZEB1 in gastric carcinoma, its correlation with the clinicopathology of gastric carcinoma, and the role of ZEB1 in invasion and metastasis in gastric carcinoma. ZEB1 expression was analyzed by immunohistochemistry and Western blot in 45 gastric carcinoma tissue samples that contained the adjacent gastric mucosa. The correlation between ZEB1 expression, the occurrence and development of gastric cancer, and clinical pathology was investigated. ZEB1 expression in the human gastric carcinoma cell line AGS was downregulated by RNA interference, and changes in ZEB1 expression corresponded with changes in the invasive and metastatic ability of AGS cells. Immunohistochemistry revealed that ZEB1 protein expression in gastric carcinoma tissues was significantly higher than in normal gastric mucosa tissues (p < 0.001). A lower degree of differentiation of gastric cancer (p = 0.009), a higher TNM (tumor, node, and metastasis) stage (p = 0.010), and a larger scope of invasion were correlated with higher expression of ZEB1 (p = 0.041, 0.002). However, the expression of ZEB1 in gastric carcinoma tissue was independent of gender, age, and tumor size (p > 0.05). Western blot results also showed that ZEB1 protein expression was significantly higher in gastric carcinoma tissue than in the adjacent normal gastric mucosa tissue (p = 0.008). A lower degree of differentiation of the gastric carcinoma correlated with a higher TNM stage, and a larger scope of invasion correlated with increased ZEB1 expression (p = 0.023). Transfection of ZEB1 siRNA in AGS cells significantly decreased the expression level of ZEB1 protein (p = 0.035). Furthermore, the number of cells that could pass through the Transwell chamber was significantly lower in the transfected group than in the non-transfected control group (p = 0.039), indicating that the suppression of ZEB1 expression could significantly reduce the invasive and metastatic ability of AGS cells (p = 0.005). Concluding, in gastric carcinoma tissue, overexpression of ZEB1 may be related to the occurrence and development as well as invasion and metastasis of gastric carcinoma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22466758     DOI: 10.1007/s11010-012-1299-6

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  38 in total

1.  Survival of metastatic gastric cancer: Significance of age, sex and race/ethnicity.

Authors:  Dongyun Yang; Andrew Hendifar; Cosima Lenz; Kayo Togawa; Felicitas Lenz; Georg Lurje; Alexandra Pohl; Thomas Winder; Yan Ning; Susan Groshen; Heinz-Josef Lenz
Journal:  J Gastrointest Oncol       Date:  2011-06

2.  Mechanisms for nicotine in the development and progression of gastrointestinal cancers.

Authors:  Kendal Jensen; Syeda Afroze; Md Kamruzzaman Munshi; Micheleine Guerrier; Shannon S Glaser
Journal:  Transl Gastrointest Cancer       Date:  2012-04

3.  DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells.

Authors:  Andreas Eger; Kirsten Aigner; Stefan Sonderegger; Brigitta Dampier; Susanne Oehler; Martin Schreiber; Geert Berx; Amparo Cano; Hartmut Beug; Roland Foisner
Journal:  Oncogene       Date:  2005-03-31       Impact factor: 9.867

4.  Downregulation of ZEB1 and overexpression of Smad7 contribute to resistance to TGF-beta1-mediated growth suppression in adult T-cell leukemia/lymphoma.

Authors:  S Nakahata; S Yamazaki; H Nakauchi; K Morishita
Journal:  Oncogene       Date:  2010-05-31       Impact factor: 9.867

5.  Semaphorin SEMA3F affects multiple signaling pathways in lung cancer cells.

Authors:  Vincent A Potiron; Girish Sharma; Patrick Nasarre; Jonathan A Clarhaut; Hellmut G Augustin; Robert M Gemmill; Joëlle Roche; Harry A Drabkin
Journal:  Cancer Res       Date:  2007-09-15       Impact factor: 12.701

6.  Identification of a zinc finger protein that inhibits IL-2 gene expression.

Authors:  T M Williams; D Moolten; J Burlein; J Romano; R Bhaerman; A Godillot; M Mellon; F J Rauscher; J A Kant
Journal:  Science       Date:  1991-12-20       Impact factor: 47.728

7.  Opposing functions of ZEB proteins in the regulation of the TGFbeta/BMP signaling pathway.

Authors:  Antonio A Postigo
Journal:  EMBO J       Date:  2003-05-15       Impact factor: 11.598

8.  The ZFHX1A gene is differentially autoregulated by its isoforms.

Authors:  Pablo A Manavella; Gonzalo Roqueiro; Douglas S Darling; Ana M Cabanillas
Journal:  Biochem Biophys Res Commun       Date:  2007-06-26       Impact factor: 3.575

9.  Down-regulation of TCF8 is involved in the leukemogenesis of adult T-cell leukemia/lymphoma.

Authors:  Tomonori Hidaka; Shingo Nakahata; Kinta Hatakeyama; Makoto Hamasaki; Kiyoshi Yamashita; Takashi Kohno; Yasuhito Arai; Tomohiko Taki; Kazuhiro Nishida; Akihiko Okayama; Yujiro Asada; Ryoji Yamaguchi; Hirohito Tsubouchi; Jun Yokota; Masafumi Taniwaki; Yujiro Higashi; Kazuhiro Morishita
Journal:  Blood       Date:  2008-05-08       Impact factor: 22.113

10.  SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions.

Authors:  Cindy Vandewalle; Joke Comijn; Bram De Craene; Petra Vermassen; Erik Bruyneel; Henriette Andersen; Eugene Tulchinsky; Frans Van Roy; Geert Berx
Journal:  Nucleic Acids Res       Date:  2005-11-24       Impact factor: 16.971

View more
  23 in total

1.  MicroRNA-342 inhibits cell proliferation and invasion in nasopharyngeal carcinoma by directly targeting ZEB1.

Authors:  Xiaoning Zhu; Wei Li; Renxian Zhang; Yutao Liu
Journal:  Oncol Lett       Date:  2018-05-22       Impact factor: 2.967

2.  miRNA-708 functions as a tumor suppressor in colorectal cancer by targeting ZEB1 through Akt/mTOR signaling pathway.

Authors:  Sinan Sun; Tianyi Hang; Boyu Zhang; Liang Zhu; Yang Wu; Xiangwei Lv; Qiang Huang; Hanhui Yao
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

3.  Clinical significance of zinc-finger E-box binding homeobox 1 mRNA levels in peritoneal washing for gastric cancer.

Authors:  Norimitsu Yabusaki; Suguru Yamada; Toshifumi Murai; Mitsuro Kanda; Daisuke Kobayashi; Chie Tanaka; Tsutomu Fujii; Goro Nakayama; Hiroyuki Sugimoto; Masahiko Koike; Shuji Nomoto; Michitaka Fujiwara; Yasuhiro Kodera
Journal:  Mol Clin Oncol       Date:  2014-11-20

Review 4.  ZEB1: at the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance.

Authors:  Peijing Zhang; Yutong Sun; Li Ma
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 5.  Prospects of circular RNAs: the regulators of drug resistance and metastasis in gastric cancer.

Authors:  Bingyu Wang; Zihao Chen; Wenbo Liu; Bibo Tan
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

6.  ZEB1 promotes the progression and metastasis of cervical squamous cell carcinoma via the promotion of epithelial-mesenchymal transition.

Authors:  Yihui Ma; Xiangyu Zheng; Jun Zhou; Ying Zhang; Kuisheng Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

7.  Porphyromonas gingivalis initiates a mesenchymal-like transition through ZEB1 in gingival epithelial cells.

Authors:  Maryta N Sztukowska; Akintunde Ojo; Saira Ahmed; Anne L Carenbauer; Qian Wang; Brain Shumway; Howard F Jenkinson; Huizhi Wang; Douglas S Darling; Richard J Lamont
Journal:  Cell Microbiol       Date:  2016-01-13       Impact factor: 3.715

8.  Long noncoding RNA SNHG22 increases ZEB1 expression via competitive binding with microRNA-429 to promote the malignant development of papillary thyroid cancer.

Authors:  Hong Gao; Xiaosong Sun; Hongdong Wang; Ying Zheng
Journal:  Cell Cycle       Date:  2020-04-19       Impact factor: 4.534

9.  Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells.

Authors:  Chun-Xiu Yuan; Zhi-Wei Zhou; Yin-Xue Yang; Zhi-Xu He; Xueji Zhang; Dong Wang; Tianxing Yang; Si-Yuan Pan; Xiao-Wu Chen; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2015-03-02       Impact factor: 4.162

10.  Clinical implication of ZEB-1 and E-cadherin expression in hepatocellular carcinoma (HCC).

Authors:  Motoyuki Hashiguchi; Shinichi Ueno; Masahiko Sakoda; Satoshi Iino; Kiyokazu Hiwatashi; Koji Minami; Kei Ando; Yuko Mataki; Kosei Maemura; Hiroyuki Shinchi; Sumiya Ishigami; Shoji Natsugoe
Journal:  BMC Cancer       Date:  2013-12-05       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.